home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Collection of Education
/
collectionofeducationcarat1997.iso
/
HEALTH
/
MED9601.ZIP
/
M9610354.TXT
< prev
next >
Wrap
Text File
|
1996-01-30
|
2KB
|
27 lines
Document 0354
DOCN M9610354
TI BUILDER v.2: improving the chemistry of a de novo design strategy.
DT 9601
AU Roe DC; Kuntz ID; Department of Pharmaceutical Chemistry, University of
California,; San Francisco 94143-0446, USA.
SO J Comput Aided Mol Des. 1995 Jun;9(3):269-82. Unique Identifier :
AIDSLINE MED/96044961
AB Significant improvements have been made to the de novo drug design
program BUILDER. The BUILDER strategy is to find molecule templates that
bind tightly to 'hot spots' in the target receptor, and then generate
bridges to join these templates. In this paper, the bridging algorithm
has been further developed to improve the chemical sense and diversity
of the bridges, as well as the robustness of the technique. The improved
algorithm is then applied to rebuild known bridges in methotrexate and
HIV protease. Finally, the entire BUILDER approach is tested by
rebuilding methotrexate de novo.
DE Algorithms Binding Sites Comparative Study Databases, Factual *Drug
Design Evaluation Studies HIV Protease Inhibitors/CHEMISTRY
Methotrexate/CHEMISTRY Models, Chemical Molecular Structure *Software
Sugar Alcohols/CHEMISTRY Support, U.S. Gov't, P.H.S. Valine/ANALOGS &
DERIVATIVES/CHEMISTRY JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).